Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Auto Added by WPeMatico
Salesforce stock climbed amid Q2 earnings and revenue that beat Wall Street targets while guidance came in above expectations. The post Salesforce Pops As Q2 Earnings, Revenue Beat Amid Strong Guidance appeared first on Investor’s Business Daily.
Everpure stock was trading up and down after-hours despite the data storage company handily beating Q2 earnings expectations. The post Everpure Posts Earnings Beat As Revenue Growth Accelerates appeared first on Investor’s Business Daily.
CrowdStrike stock climbed amid Q2 earnings and revenue that topped estimates while the cybersecurity firm’s October quarter guidance came in above views. The post CrowdStrike Stock Climbs As Earnings, Revenue, Outlook Top Views appeared first on Investor’s Business Daily.
Okta reported Q2 earnings and revenue that topped estimates while the cybersecurity firm’s sales outlook came in above views. The post Okta Earnings Top Estimates. Cybersecurity Firm’s Sales Outlook Above Views. appeared first on Investor’s Business Daily.
Dollar Tree, Dollar General and Five Below set to report earnings amid price-target hikes. The post Dollar Stores In Earnings Spotlight With 2 Stocks In Buy Zones appeared first on Investor’s Business Daily.
Medpace stock is back below a buy point of 628.92. The medical research contractor delivered an earnings beat for its second quarter. The post Medpace Stock Hovers Near Entry, Offers Second Chance After July Spike appeared first on Investor’s Business…
Shopify stock nears a new buy point as rising Sidekick usage bolsters views that the e-commerce firm is an artificial intelligence winner. The post Shopify, IBD Stock Of The Day, Nears Buy Point As AI Shopping Strategy Clicks appeared first…
Vanguard bolsters its wealth custody, advisory offerings with a reported $4 billion acquisition for AI-forward platform Altruist. The post Vanguard Takes On Fidelity, Charles Schwab With $4 Billion Altruist Deal appeared first on Investor’s Business Daily.
Revolution Medicines won FDA approval Wednesday for the pancreatic cancer treatment that once caused its stock to skyrocket. The post FDA Approves ‘Unprecedented’ Pancreatic Cancer Drug appeared first on Investor’s Business Daily.
Abercrombie & Fitch stock took off Wednesday morning. It got a tariff refund boost, but there’s more to the story. The post Why Abercrombie & Fitch Stock Is Soaring Despite It Being The Year 2026 appeared first on Investor’s Business…
